Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BvfiledCriticalFerring Bv
Priority to UY27517ApriorityCriticalpatent/UY27517A1/en
Publication of UY27517A1publicationCriticalpatent/UY27517A1/en
Compuestos de acuerdo con la fórmula donde R1 es H o CN, X1 es S, O, SO2 O CH2, X2 es CO, CH2 o un enlace covalente, Het es un heterociclo que contiene nitrógeno y n es 1-5 nuevos. Los compuestos de la invención son inhibidores de depeptidil peptidasa IV. Composiciones farmacéuticas de los compuestos de la invención, o sales farmacéuticamente aceptables de los mismos, que son útiles en el tratamiento de interalia, diabetes tipo2.Compounds according to the formula where R1 is H or CN, X1 is S, O, SO2 OR CH2, X2 is CO, CH2 or a covalent bond, Het is a nitrogen-containing heterocycle and n is 1-5 new. The compounds of the invention are Depeptidyl peptidase IV inhibitors. Pharmaceutical compositions of the compounds of the invention, or pharmaceutically acceptable salts thereof, which are useful in the treatment of interalia, type2 diabetes.
UY27517A2002-10-252002-10-25
DIPEPTIDIL PEPTIDASA IV INHIBITORS
UY27517A1
(en)
HPPARDELTA ACTIVATING COMPOUNDS, PHARMACEUTICAL COMPOSITION, ITS USE IN THE PREPARATION OF MEDICINES, METHOD FOR THE TREATMENT OF DISEASES MEDIATED BY HPPARDELTA